Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity

This work reports the fabrication of layer-by-layer (LbL) polyelectrolyte coated erythrocyte carriers that provide a simple means for controlling the burst and subsequent release of lysozyme. Erythrocytes were loaded with RITC-lysozyme as model compound via the hypotonic dialysis method. An encapsul...

Full description

Bibliographic Details
Main Authors: Luo, Rongcong, Shaillender, Mutukumaraswamy, Venkatraman, Subbu S., Neu, Björn
Other Authors: School of Chemical and Biomedical Engineering
Format: Journal Article
Language:English
Published: 2013
Subjects:
Online Access:https://hdl.handle.net/10356/97719
http://hdl.handle.net/10220/18105
_version_ 1826119699747831808
author Luo, Rongcong
Shaillender, Mutukumaraswamy
Venkatraman, Subbu S.
Neu, Björn
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Luo, Rongcong
Shaillender, Mutukumaraswamy
Venkatraman, Subbu S.
Neu, Björn
author_sort Luo, Rongcong
collection NTU
description This work reports the fabrication of layer-by-layer (LbL) polyelectrolyte coated erythrocyte carriers that provide a simple means for controlling the burst and subsequent release of lysozyme. Erythrocytes were loaded with RITC-lysozyme as model compound via the hypotonic dialysis method. An encapsulation efficiency of 41.6% and a loading amount of 12.7 pg/cell was achieved. It is demonstrated that these carriers maintain their shape and integrity similar to natural erythrocytes after the encapsulation procedures, and achieve a uniform distribution of the encapsulated lysozyme. The erythrocyte carriers were fixed with glutaraldehyde and then successfully coated with biocompatible polyelectrolytes, poly-l-lysine hydrobromide and dextran sulfate, using the LbL method. It is demonstrated that the release profile of the encapsulated macromolecule can be regulated by adjusting the number of polyelectrolyte layers. Furthermore by adjusting the concentrations of the cross linking agent the activity of the encapsulated lysozyme can be well preserved. These core–shell microcapsules, consisting of erythrocytes loaded with bioactive substances and coated with a polyelectrolyte multilayer shell, hold promise for a new type of biocompatible and biodegradable drug delivery system.
first_indexed 2024-10-01T05:04:22Z
format Journal Article
id ntu-10356/97719
institution Nanyang Technological University
language English
last_indexed 2024-10-01T05:04:22Z
publishDate 2013
record_format dspace
spelling ntu-10356/977192020-06-01T10:01:58Z Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity Luo, Rongcong Shaillender, Mutukumaraswamy Venkatraman, Subbu S. Neu, Björn School of Chemical and Biomedical Engineering School of Materials Science & Engineering DRNTU::Engineering::Materials::Biomaterials This work reports the fabrication of layer-by-layer (LbL) polyelectrolyte coated erythrocyte carriers that provide a simple means for controlling the burst and subsequent release of lysozyme. Erythrocytes were loaded with RITC-lysozyme as model compound via the hypotonic dialysis method. An encapsulation efficiency of 41.6% and a loading amount of 12.7 pg/cell was achieved. It is demonstrated that these carriers maintain their shape and integrity similar to natural erythrocytes after the encapsulation procedures, and achieve a uniform distribution of the encapsulated lysozyme. The erythrocyte carriers were fixed with glutaraldehyde and then successfully coated with biocompatible polyelectrolytes, poly-l-lysine hydrobromide and dextran sulfate, using the LbL method. It is demonstrated that the release profile of the encapsulated macromolecule can be regulated by adjusting the number of polyelectrolyte layers. Furthermore by adjusting the concentrations of the cross linking agent the activity of the encapsulated lysozyme can be well preserved. These core–shell microcapsules, consisting of erythrocytes loaded with bioactive substances and coated with a polyelectrolyte multilayer shell, hold promise for a new type of biocompatible and biodegradable drug delivery system. 2013-12-05T06:14:20Z 2019-12-06T19:45:50Z 2013-12-05T06:14:20Z 2019-12-06T19:45:50Z 2012 2012 Journal Article Luo, R., Shaillender, M., Venkatraman, S. S., & Neu, B. (2012). Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity. Journal of materials science : materials in medicine, 23(1), 63-71. https://hdl.handle.net/10356/97719 http://hdl.handle.net/10220/18105 10.1007/s10856-011-4485-2 en Journal of materials science : Materials in medicine
spellingShingle DRNTU::Engineering::Materials::Biomaterials
Luo, Rongcong
Shaillender, Mutukumaraswamy
Venkatraman, Subbu S.
Neu, Björn
Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity
title Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity
title_full Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity
title_fullStr Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity
title_full_unstemmed Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity
title_short Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity
title_sort engineering of erythrocyte based drug carriers control of protein release and bioactivity
topic DRNTU::Engineering::Materials::Biomaterials
url https://hdl.handle.net/10356/97719
http://hdl.handle.net/10220/18105
work_keys_str_mv AT luorongcong engineeringoferythrocytebaseddrugcarrierscontrolofproteinreleaseandbioactivity
AT shaillendermutukumaraswamy engineeringoferythrocytebaseddrugcarrierscontrolofproteinreleaseandbioactivity
AT venkatramansubbus engineeringoferythrocytebaseddrugcarrierscontrolofproteinreleaseandbioactivity
AT neubjorn engineeringoferythrocytebaseddrugcarrierscontrolofproteinreleaseandbioactivity